MCN-04-October-2020 Related News
UK regulatory landscape: import and export of medical cannabis
In this article, Eleri Williams, Associate at Hill Dickinson Life Sciences team, sets out an overview of the current legal and regulatory position on...
Top tips for safely launching your medical cannabis products in Europe
Marc Stegeman of ProPharma Group outlines the factors business owners need to consider when moving into the growing European market.
The continent of Europe consists...
Cannabis nursing in the USA
American Cannabis Nurses Association President Eloise Theisen speaks to MCN about cannabis research, policy and clinical practice.
Eloise Theisen is President of the American Cannabis...
Malta offers one of the world’s strongest economic support packages
Malta Enterprise has been trusted to administer a wide-ranging package of support for individuals and businesses affected by the COVID-19 pandemic.
As in the rest...
Discussing the need for evidence-based drug policy
Science for Democracy co-founder and former Italian Senator Marco Perduca tells MCN about the need for evidence-based drug policy.
International platform Science for Democracy (SfD)...
ICANNA: cannabis in Slovenia
MCN speaks to the International Institute for Cannabinoids about cannabis education, policy and prohibition in Slovenia.
The International Institute for Cannabinoids (ICANNA) is a non-profit...
The LeafCann Group in 2020
Australia’s LeafCann Group is highly ambitious and dedicated to providing affordable, high quality products.
LeafCann’s mission is to supply the most effective and affordable precision...
Anspec: leading the way in Australia’s medicinal cannabis sector
Anspec, the largest distributor of medicinal cannabis in Australia, is committed to ongoing development and innovation within the sector.
Australian company Anspec has been in...